Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q2 2022 Earnings Conference Call August 5, 2021 4:30 PM ET Company Participants Aron Feingold - Head of Corporate Communications & Investor Relations Officer Sandy Macrae - President & Chief Executive Officer Prathyusha Duraibabu - Chief Financial Officer Rob Schott - Senior Vice President & Head of Development Jason Fontenot - Senior Vice President & Chief Scientific Officer Mark McClung - Executive Vice President & Chief Business Officer Conference Call Participant ...